White Paper | 2024 Annual Meeting | Enhancing Study Designs and Interpretation of Interim Overall Survival Data in Oncology Trial | November 9, 2024 Share
White Paper | 2024 Annual Meeting | Framework for Integrating Change in ctDNA Levels in Advanced Cancer Clinical Trials to Support Meta-analyses for Intermediate Endpoint Validation | November 9, 2024 Share
Public Comment | Cancer Clinical Trial Eligibility Criteria: Performance Status | August 2, 2024 Share
White Paper | 2023 Annual Meeting | Incorporating Pragmatic Elements in Study Designs to Enhance Oncology Randomized Clinical Trials | November 14, 2023 Share
White Paper | 2023 Annual Meeting | Maximizing Data from Academic-Led Studies for Regulatory Decision-Making | November 14, 2023 Share
White Paper | 2023 Annual Meeting | Interpreting Data from Dose-Finding Studies in Early Phase Oncology Trials to Determine the Optimal Dose | November 14, 2023 Share
White Paper | 2022 Annual Meeting | Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Clinical Trials | November 18, 2022 Share
White Paper | 2022 Annual Meeting | Supporting a Patient-Centric Approach to Dose Optimization in Oncology: The Essential Role of Patient-Reported Outcomes (PROs) | November 18, 2022 Share
